Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Iron

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Iron.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
5.218
Iron
  1. Parenteral iron therapy and phosphorus homeostasis: A review. Am J Hematol. 2021 05 01; 96(5):606-616.
    View in: PubMed
    Score: 0.693
  2. Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort. Nephrol Dial Transplant. 2017 02 01; 32(2):370-377.
    View in: PubMed
    Score: 0.524
  3. Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1814-21.
    View in: PubMed
    Score: 0.474
  4. Interpreting tests of iron sufficiency in patients with ESRD: inflammation, evidence, and recommendations. Nephrol News Issues. 2014 Feb; 28(2):6-9.
    View in: PubMed
    Score: 0.426
  5. Is iron maintenance therapy better than load and hold? J Am Soc Nephrol. 2013 Jun; 24(7):1028-31.
    View in: PubMed
    Score: 0.408
  6. Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol. 2009 Feb; 4(2):435-41.
    View in: PubMed
    Score: 0.299
  7. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1691-701.
    View in: PubMed
    Score: 0.295
  8. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol. 2005 Oct; 16(10):3070-80.
    View in: PubMed
    Score: 0.236
  9. A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004 Apr; 43(4):671-84.
    View in: PubMed
    Score: 0.215
  10. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant. 2004 Jan; 19(1):141-9.
    View in: PubMed
    Score: 0.212
  11. Association of iron therapy with incidence of chronic kidney disease. Eur J Haematol. 2023 Dec; 111(6):872-880.
    View in: PubMed
    Score: 0.207
  12. Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence. J Nephrol. 2022 04; 35(3):875-888.
    View in: PubMed
    Score: 0.186
  13. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis. 1998 Feb; 31(2):263-72.
    View in: PubMed
    Score: 0.140
  14. Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2017; 46(2):120-130.
    View in: PubMed
    Score: 0.135
  15. New Options for Iron Supplementation in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2016 Mar; 67(3):367-75.
    View in: PubMed
    Score: 0.121
  16. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2013 Nov; 28(11):2889-98.
    View in: PubMed
    Score: 0.105
  17. Iron therapy in chronic kidney disease: current controversies. J Ren Care. 2009 Dec; 35 Suppl 2:14-24.
    View in: PubMed
    Score: 0.080
  18. Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol. 2009 Mar; 20(3):479-87.
    View in: PubMed
    Score: 0.075
  19. Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol. 2009; 29(6):571-81.
    View in: PubMed
    Score: 0.075
  20. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008 Oct; 52(4):727-36.
    View in: PubMed
    Score: 0.073
  21. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis. 2005 Aug; 46(2):290-300.
    View in: PubMed
    Score: 0.059
  22. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003 Oct; 42(4):761-73.
    View in: PubMed
    Score: 0.052
  23. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001 Mar; 37(3):564-72.
    View in: PubMed
    Score: 0.043
  24. Diagnosis of iron deficiency in ESRD patients. Am J Kidney Dis. 1997 Sep; 30(3):455-6.
    View in: PubMed
    Score: 0.034
  25. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis. 1995 Aug; 26(2):292-9.
    View in: PubMed
    Score: 0.030
  26. Erythropoietin in kidney disease and type 2 diabetes. N Engl J Med. 2011 01 27; 364(4):384-5; author reply 385-6.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.